Dermapharm Holding SE (ETR:DMP) shareholders are probably feeling a little disappointed, since its shares fell 2.9% to €34.70 in the week after its latest quarterly results. It was a workmanlike ...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But in any portfolio, there are likely to be some stocks that fall ...

Grünwald, 7 July 2021 - Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, is expanding its group of companies via Dermapharm AG to include an investment ...

Archimed has acquired DermaPharm, a developer and manufacturer of skincare products. Headquartered in Fårup, Denmark and founded in 1980, DermaPharm develops and manufactures hypoallergenic, ...

Board of Management confirms full-year guidance for 2025, continues to expect consolidated revenue of EUR 1,160–1,200 million and increase in adjusted EBITDA to EUR 322–332 million Organic growth in ...

The Riverside Co. has announced plans to sell Spanish portfolio company Euromed Botanicals S.A., a supplier of herbal extracts and natural active substances, to German pharmaceutical company ...

DGAP-News: Dermapharm Holding SE / Key word(s): Half Year Results/Preliminary Results Dermapharm Holding SE: Successful first half of 2022 in challenging market environment 23.08.2022 / 07:30 The ...

» Consolidated revenue up year on year by 10.1% to EUR 471.1 million » Adjusted consolidated EBITDA grew by 8.5% to EUR 148.7 million Grünwald, 7 September 2022 – Dermapharm Holding SE ("Dermapharm"), ...

BERLIN, Feb 9 (Reuters) - Dermapharm DMPG.DE aims to start making the COVID-19 vaccine from BioNTech 22UAy.DE and U.S. partner Pfizer PFE.N at a second site in Germany in May, its chief executive said ...

DGAP-Ad-hoc: Dermapharm Holding SE / Key word(s): Takeover Dermapharm Holding SE: Acquisition of C³ Cannabinoid Compound Company GmbH 15-Dec-2021 / 13:45 CET/CEST Disclosure of an inside information ...

FRANKFURT (Reuters) - Privately-held German generic drugmaker Dermapharm has attracted interest from buyout groups in a potential 1 billion euro (£730.3 million) deal after being put up for sale by ...